stella
beta
Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hypersomnolence — Stella
Home
/
Narcolepsy
/
Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hypersomnolence
View on ClinicalTrials.gov
Recruiting
Back to Narcolepsy trials
Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hypersomnolence
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
France
University Hospital of Montpellier, Montpellier